# Auransa

**Canonical:** https://apis.io/providers/auransa/  
**Website:** https://www.auransa.com/  
**APIs profiled:** 0

Auransa Inc. is a clinical-stage, AI-native biopharmaceutical company based in Palo Alto, California, founded in 2014 by Pek Lum. Auransa uses its proprietary SMarTR Engine — a hypothesis-free machine learning platform that mines human disease data such as RNA transcriptome and gene-expression profiles — to discover novel small-molecule therapeutics without starting from a predefined drug target. The company has analyzed more than 500,000 gene-expression profiles across roughly 70 diseases to identify molecular disease subtypes and match them to candidate compounds. Its lead program, AU-409, is a first-in-human Phase 1 candidate for liver cancer (hepatocellular carcinoma), with additional pipeline work in heart-safe chemotherapy and other oncology indications. Auransa is a DCVC / DCVC Bio portfolio company, also backed by Lux Capital, 11.2 Capital, and Harmonix Fund. Auransa is a private drug-discovery company and does not publish a public API, developer portal, or SDK; this profile captures its identity and web presence in the API Evangelist network.

## Kin Score — 4.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 4.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Auransa Domain Security** — TLSv1.3 · HSTS

## Tags

Company, Biotechnology, Pharmaceuticals, Drug Discovery, Artificial Intelligence, Machine-Learning, Oncology, Life Sciences, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/auransa/). Scores are computed from the provider's own public artifacts under a published rubric.